Concepedia

Mahmoud Elsawy

ME

11

Publications

853

Citations

11

H-Index

2015

Active since

Affiliations

Dalhousie University(Current)

Stanford University

University of Washington

University of Maryland, Baltimore

Moffitt Cancer Center

Mahmoud Elsawy is an author at Dalhousie University specializing in hematology, medicine, and outcomes research.

ORCID

Top concepts

Publications per year

2015–2023

11

Publications

11

Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma

Jason R. Westin, Olalekan O. Oluwole, Marie José Kersten et al. · New England Journal of Medicine · 2023 · 359 citations · Full text

Development and Validation of a Novel Acute Myeloid Leukemia–Composite Model to Estimate Risks of Mortality

Mohamed L. Sorror, Barry E. Storer, Amir T. Fathi et al. · JAMA Oncology · 2017 · 168 citations · Full text

Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma

Mahmoud Elsawy, Julio C. Chávez, Irit Avivi et al. · Blood · 2022 · 69 citations · Full text

, , +19

Multi‐centre validation of the prognostic value of the haematopoietic cell transplantation‐ specific comorbidity index among recipient of allogeneic haematopoietic cell transplantation

Mahmoud Elsawy, Barry E. Storer, Michael A. Pulsipher et al. · British Journal of Haematology · 2015 · 54 citations · Full text

Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma

Jason R. Westin, Frederick L. Locke, Michael Dickinson et al. · Clinical Cancer Research · 2023 · 46 citations · Full text

Rows per page

1–5 of 11